Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia

Completed · Phase 3

Conditions studied: Overactive Bladder

In brief

This study will assess the long-term safety of vibegron when dosed up to 52 weeks in men with overactive bladder (OAB) symptoms on pharmacological therapy for Benign Prostatic Hyperplasia (BPH) who previously completed treatment in Study URO-901-3005 (NCT03902080).

Key facts

Study ID

NCT04103450

Run by

Urovant Sciences GmbH

People needed

276

Starts

2019-09-19

Expected to finish

2022-07-29

Last updated by the study team

2024-08-21

Who can join

Age: 45 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Participant has completed participation of the 24-week double-blind treatment period in Study URO-901-3005 (NCT03902080) and demonstrated compliance with the study procedures and study medication schedule in the opinion of the investigator.
• Participant is capable of giving written informed consent, which includes compliance with the requirements and restrictions listed in the consent form.
• Participant has the ability to continue to receive a stable dose of Benign Prostatic Hyperplasia (BPH) treatment with either a) alpha blocker monotherapy or b) alpha blocker +5-ARI.
• In the opinion of the investigator, the participant is able and willing to comply with the requirements of the protocol, including completing study questionnaires and the Bladder Diary.

You may not qualify if…

• Participant experienced any Serious Adverse Event in Study URO-901-3005 that was reported as "possibly or probably related" to study treatment by the investigator.
• Participant is using any prohibited medications
• Participant has uncontrolled hyperglycemia (defined as fasting blood glucose >150 milligrams per deciliter [mg/dL] or 8.33 millimoles per Liter [mmol/L] and/or non-fasting blood glucose >200 mg/dL or 11.1 mmol/L) based on most recent available lab results in Study URO-901-3005 or uncontrolled in the opinion of the investigator.
• Participant has uncontrolled hypertension (systolic blood pressure of ≥180 millimeters of mercury [mmHg] and/or diastolic blood pressure of ≥100 mmHg) or has a resting heart rate (by pulse) >100 beats per minute.
• Participant has systolic blood pressures ≥160 mmHg but <180 mmHg, unless deemed by the investigator as safe to proceed in this study and able to complete the study per protocol.
• Participant has current evidence of any clinically significant condition, therapy, lab abnormality, or other circumstances that might, in the opinion of the investigator, confound the results of the study, interfere with the participant's ability to comply with study procedures, or make participation in the study not in the participant's best interest.

Where it is running

• Private Practice — Huntsville, Alabama, United States
• Clinical Trials Research — Lincoln, California, United States
• American Institute of Research — Los Angeles, California, United States
• Tri Valley Urology Medical Group — Murrieta, California, United States
• Northern California Research Corp — Sacramento, California, United States
• San Diego Clinical Trials — San Diego, California, United States
• Skyline Urology — Torrance, California, United States
• Imagine Research of Palm Beach County - Urology — Boynton Beach, Florida, United States
• Tampa Bay Medical Research — Clearwater, Florida, United States
• Quantum Clinical Trials — Miami, Florida, United States
• Urology Center Of Florida — Pompano Beach, Florida, United States
• Precision Clinical Research — Sunrise, Florida, United States
• Clinical Research of Central Florida — Winter Haven, Florida, United States
• DelRicht Research — New Orleans, Louisiana, United States
• Regional Urology, LLC — Shreveport, Louisiana, United States
• Boston Clinical Trials Inc - Urology — Boston, Massachusetts, United States
• Bay State Clinical Trials, Inc. — Watertown, Massachusetts, United States
• Beaumont Hospital Royal Oak - Urology Research — Royal Oak, Michigan, United States
• CentraCare Clinic - Adult & Pediatric Urology — Sartell, Minnesota, United States
• Poplar Bluff Urology — Poplar Bluff, Missouri, United States
• Adult & Pediatric Urology P.C. - Urology — Omaha, Nebraska, United States
• Excel Clinical Research - Internal Medicine — Las Vegas, Nevada, United States
• Private Practice — Las Vegas, Nevada, United States
• Premier Urology Group, LLC — Edison, New Jersey, United States
• New Jersey Urology NJU — Englewood, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.